<DOC>
	<DOCNO>NCT01878643</DOCNO>
	<brief_summary>The purpose study : - determine effect inhale antibiotic airway bacteria ventilate patient - determine effect inhale antibiotic respiratory infection</brief_summary>
	<brief_title>Reduction Bacterial Resistance With Inhaled Antibiotics Intensive Care Unit</brief_title>
	<detailed_description>Double-blind randomize placebo control study examine effect aerosolize antibiotic respiratory infection sign symptoms bacterial eradication resistance . Systemic antibiotic administer responsible physician</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>mechanical ventilation great 3 day great equal 18 year survival great 14 day organisms Gram stain increase purulent secretion pregnancy allergy drug administer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>aerosolize antibiotic</keyword>
	<keyword>ventilator-associated pneumonia</keyword>
	<keyword>bacterial resistance</keyword>
	<keyword>ventilator -associated tracheobronchitis</keyword>
	<keyword>clinical pulmonary infection score</keyword>
</DOC>